Shilpa Medicare's Unit VI Facility Receives SFDA GMP Certification with Zero Observations

Shilpa Medicare Limited's Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification. The facility, which is engaged in the manufacture, testing, storage and release of finished dosage forms in the category of Oral Films and Transdermal Patches, underwent a full GMP inspection from 18 — 20° Feb 2025, focusing on Ondansetron Oral Film drug product. The inspection was closed with ZERO observations. This facility is currently supplying Oral Films to US, Australia and other Emerging countries and is approved by European Medicine Agency, Europe.